enGene Holdings Inc.
ENGN
$8.65
-$0.17-1.87%
NASDAQ
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.61% | 4.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.41% | 1.92% | |||
| Operating Income | -10.41% | -1.92% | |||
| Income Before Tax | -12.42% | -3.97% | |||
| Income Tax Expenses | -0.42% | 1,233.33% | |||
| Earnings from Continuing Operations | -12.30% | -4.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.30% | -4.87% | |||
| EBIT | -10.41% | -1.92% | |||
| EBITDA | -10.36% | -1.91% | |||
| EPS Basic | -12.13% | -4.78% | |||
| Normalized Basic EPS | -12.26% | -3.88% | |||
| EPS Diluted | -12.13% | -4.78% | |||
| Normalized Diluted EPS | -12.26% | -3.88% | |||
| Average Basic Shares Outstanding | 0.15% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||